Filing Details

Accession Number:
0001415889-24-012744
Form Type:
4
Zero Holdings:
No
Publication Time:
2024-05-09 16:38:35
Reporting Period:
2024-05-07
Accepted Time:
2024-05-09 16:38:35
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1231457 Genelux Corp GNLX Pharmaceutical Preparations (2834) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1937513 Aladar Szalay C/O Genelux Corporation,
2625 Townsgate Road, Suite 230
Westlake Village CA 91361
No No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2024-05-07 6,025 $3.67 1,189,706 No 4 S Indirect By Trust
Common Stock Disposition 2024-05-08 13,919 $3.82 1,175,787 No 4 S Indirect By Trust
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Indirect By Trust
No 4 S Indirect By Trust
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 5,000 Indirect By Spouse
Common Stock 2,258,760 Indirect By Trust
Common Stock 550,000 Indirect By Trust
Footnotes
  1. The "Amount" and "Price" reported in this Column 4 reflect the aggregate number and weighted-average price, respectively, of shares sold. These shares were sold in multiple transactions at prices ranging from $3.595 to $3.76, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth herein.
  2. Shares held by The Szalay 2010 Retained Annuity Trust.
  3. The "Amount" and "Price" reported in this Column 4 reflect the aggregate number and weighted-average price, respectively, of shares sold. These shares were sold in multiple transactions at prices ranging from $3.75 to $3.96, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth herein.
  4. Shares held by The Szalay 2009 Irrevocable Trust.
  5. Shares held by The Szalay 2010 Children's Trust.